These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 9537221

  • 1. The azimilide post-infarct survival evaluation (ALIVE) trial.
    Camm AJ, Karam R, Pratt CM.
    Am J Cardiol; 1998 Mar 19; 81(6A):35D-39D. PubMed ID: 9537221
    [Abstract] [Full Text] [Related]

  • 2. Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification.
    Camm AJ, Pratt CM, Schwartz PJ, Al-Khalidi HR, Spyt MJ, Holroyde MJ, Karam R, Sonnenblick EH, Brum JM, AzimiLide post Infarct surVival Evaluation (ALIVE) Investigators.
    Circulation; 2004 Mar 02; 109(8):990-6. PubMed ID: 14967728
    [Abstract] [Full Text] [Related]

  • 3. Azimilide dihydrochloride, a novel antiarrhythmic agent.
    Karam R, Marcello S, Brooks RR, Corey AE, Moore A.
    Am J Cardiol; 1998 Mar 19; 81(6A):40D-46D. PubMed ID: 9537222
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial.
    Pratt CM, Singh SN, Al-Khalidi HR, Brum JM, Holroyde MJ, Marcello SR, Schwartz PJ, Camm AJ, ALIVE Investigators.
    J Am Coll Cardiol; 2004 Apr 07; 43(7):1211-6. PubMed ID: 15063432
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Azimilide for atrial fibrillation: clinical trial results and implications.
    Pritchett EL, Marcello SR.
    Card Electrophysiol Rev; 2003 Sep 07; 7(3):215-9. PubMed ID: 14739716
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial).
    Malik M, Camm AJ, Janse MJ, Julian DG, Frangin GA, Schwartz PJ.
    J Am Coll Cardiol; 2000 Apr 07; 35(5):1263-75. PubMed ID: 10758969
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of azimilide, a new class III antiarrhythmic drug, on reentrant circuits causing ventricular tachycardia and fibrillation in a canine model of myocardial infarction.
    Schmitt H, Cabo C, Coromilas JC, Wit AL.
    J Cardiovasc Electrophysiol; 2001 Sep 07; 12(9):1025-33. PubMed ID: 11573692
    [Abstract] [Full Text] [Related]

  • 17. Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators.
    Pritchett EL, Page RL, Connolly SJ, Marcello SR, Schnell DJ, Wilkinson WE.
    J Am Coll Cardiol; 2000 Sep 07; 36(3):794-802. PubMed ID: 10987602
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Arrhythmic risk stratification of post-myocardial infarction patients.
    Naccarella F, Lepera G, Rolli A.
    Curr Opin Cardiol; 2000 Jan 07; 15(1):1-6. PubMed ID: 10666655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.